Status:
COMPLETED
Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005
Lead Sponsor:
Bayside Health
Conditions:
Respiratory Distress Syndrome, Adult
Respiratory Insufficiency
Eligibility:
All Genders
16+ years
Brief Summary
Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical setting...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients receiving ECMO in Australia and New Zealand
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
End Date :
August 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00157144
Start Date
October 1 2004
End Date
August 1 2006
Last Update
March 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3004